You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

fg-4592

Showing 1 - 9 of 9
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Primary MDS Classified as Very Low, Low or Intermediate Risk With <5% Blasts Trial in China (FG-4592, Placebo)

Active, not recruiting
  • Primary MDS Classified as Very Low, Low or Intermediate Risk With <5% Blasts
  • FG-4592
  • Placebo
  • Bengbu, Anhui, China
  • +37 more
Aug 17, 2022

Anemia Trial in China (FG-4592, Epoetin Alfa)

Completed
  • Anemia
  • FG-4592
  • Epoetin Alfa
  • Hefei, Anhui, China
  • +30 more
Aug 23, 2017

Anemia Trial in China (FG-4592, Placebo)

Completed
  • Anemia
  • FG-4592
  • Placebo
  • Hefei, Anhui, China
  • +29 more
Aug 23, 2017

Pharmacokinetics of FG-4592, Healthy Subjects Trial in Berlin (Warfarin, FG-4592)

Completed
  • Pharmacokinetics of FG-4592
  • Healthy Subjects
  • Berlin, Germany
    Parexel International GmbH
Sep 26, 2014

PK for FG-4592, Healthy Subjects Trial in Berlin (FG-4592, Placebo)

Completed
  • PK for FG-4592
  • Healthy Subjects
  • FG-4592
  • Placebo
  • Berlin, Germany
    Parexel International GmbH
Jun 10, 2014

PK of FG-4592, Hepatic Insufficiency, Healthy Subjects Trial in Sofia (FG-4592)

Completed
  • PK of FG-4592
  • +2 more
  • FG-4592
  • Sofia, Bulgaria
    COMAC
Jun 9, 2014

Anemia in Chronic Kidney Disease Trial in China (FG-4592, Placebo)

Completed
  • Anemia in Chronic Kidney Disease
  • FG-4592
  • Placebo
  • Beijing, China
  • +12 more
Feb 27, 2014

Anemia in End Stage Renal Disease Trial in China (FG-4592, Epoetin Alfa)

Completed
  • Anemia in End Stage Renal Disease
  • FG-4592
  • Epoetin Alfa
  • Beijing, China
  • +8 more
Jan 31, 2013

Healthy Adult Subjects Trial (FG-4592)

Completed
  • Healthy Adult Subjects
  • FG-4592
  • (no location specified)
Jun 17, 2011